Literature DB >> 31654036

High HDL-C levels reduce the risk of obstructive coronary artery disease in asymptomatic diabetics who achieved optimal glycemic control.

Gyung-Min Park1, Yongjik Lee2, Ki-Bum Won3, Yu Jin Yang1,4, Sangwoo Park1, Soe Hee Ann1, Yong-Giun Kim1, Dong Hyun Yang5, Joon-Won Kang5, Tae-Hwan Lim5, Hong-Kyu Kim6, Jaewon Choe6, Seung-Whan Lee4, Young-Hak Kim4, Shin-Jae Kim1, Sang-Gon Lee1.   

Abstract

The benefit of a high level of high-density lipoprotein cholesterol (HDL-C) against coronary atherosclerosis risk after achieving optimal glycemic control (OGC) in diabetics remains uncertain. We aimed to evaluate the association between HDL-C and obstructive coronary artery disease (CAD) according to OGC status in diabetics. We analyzed 1,114 asymptomatic diabetics who underwent coronary computed tomographic angiography in a health examination. OGC was defined as hemoglobin A1C <7.0%. Obstructive CAD was defined as the presence of plaques with ≥50% stenosis. Patients with a high HDL-C level (≥40 mg/dL and ≥50 mg/dL in males and females, respectively) showed a lower prevalence of obstructive CAD than those with a low HDL-C level in the OGC group (8.9% vs. 14.4%; p = 0.046), but not in the non-OGC group (22.3% vs. 23.2%, p = 0.850). Multiple logistic regression models showed that the risk for obstructive CAD was lower in patients with a high HDL-C level than in those with a low HDL-C level in the OGC group (odds ratio: 0.584, 95% confidence interval: 0.343-0.995; p = 0.048), but not in the non-OGC group. In conclusion, it may be necessary to maintain a high HDL-C level to reduce the risk of obstructive CAD in asymptomatic diabetics after OGC is achieved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31654036      PMCID: PMC6814721          DOI: 10.1038/s41598-019-51732-6

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  34 in total

Review 1.  Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies.

Authors:  Rachel Huxley; Federica Barzi; Mark Woodward
Journal:  BMJ       Date:  2005-12-21

2.  Impact of optimal glycemic control on the progression of coronary artery calcification in asymptomatic patients with diabetes.

Authors:  Ki-Bum Won; Donghee Han; Ji Hyun Lee; Sang-Eun Lee; Ji Min Sung; Su-Yeon Choi; Eun Ju Chun; Sung Hak Park; Hae-Won Han; Jidong Sung; Hae Ok Jung; Hyuk-Jae Chang
Journal:  Int J Cardiol       Date:  2018-09-01       Impact factor: 4.164

Review 3.  Hyperglycemia and cardiovascular disease in type 2 diabetes.

Authors:  M Laakso
Journal:  Diabetes       Date:  1999-05       Impact factor: 9.461

4.  Impact of diabetes on coronary artery disease in women and men: a meta-analysis of prospective studies.

Authors:  W L Lee; A M Cheung; D Cape; B Zinman
Journal:  Diabetes Care       Date:  2000-07       Impact factor: 19.112

5.  Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status.

Authors: 
Journal:  J Am Coll Cardiol       Date:  2000-04       Impact factor: 24.094

6.  Size-specific dose estimates for adult patients at CT of the torso.

Authors:  Jodie A Christner; Natalie N Braun; Megan C Jacobsen; Rickey E Carter; James M Kofler; Cynthia H McCollough
Journal:  Radiology       Date:  2012-10-22       Impact factor: 11.105

7.  Effects of torcetrapib in patients at high risk for coronary events.

Authors:  Philip J Barter; Mark Caulfield; Mats Eriksson; Scott M Grundy; John J P Kastelein; Michel Komajda; Jose Lopez-Sendon; Lori Mosca; Jean-Claude Tardif; David D Waters; Charles L Shear; James H Revkin; Kevin A Buhr; Marian R Fisher; Alan R Tall; Bryan Brewer
Journal:  N Engl J Med       Date:  2007-11-05       Impact factor: 91.245

8.  Diagnostic accuracy of 64-slice computed tomography coronary angiography: a prospective, multicenter, multivendor study.

Authors:  W Bob Meijboom; Matthijs F L Meijs; Joanne D Schuijf; Maarten J Cramer; Nico R Mollet; Carlos A G van Mieghem; Koen Nieman; Jacob M van Werkhoven; Gabija Pundziute; Annick C Weustink; Alexander M de Vos; Francesca Pugliese; Benno Rensing; J Wouter Jukema; Jeroen J Bax; Mathias Prokop; Pieter A Doevendans; Myriam G M Hunink; Gabriel P Krestin; Pim J de Feyter
Journal:  J Am Coll Cardiol       Date:  2008-12-16       Impact factor: 24.094

9.  Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis.

Authors:  Mitsuhiro Yokoyama; Hideki Origasa; Masunori Matsuzaki; Yuji Matsuzawa; Yasushi Saito; Yuichi Ishikawa; Shinichi Oikawa; Jun Sasaki; Hitoshi Hishida; Hiroshige Itakura; Toru Kita; Akira Kitabatake; Noriaki Nakaya; Toshiie Sakata; Kazuyuki Shimada; Kunio Shirato
Journal:  Lancet       Date:  2007-03-31       Impact factor: 79.321

10.  Coronary computed tomography angiography with model-based iterative reconstruction using a radiation exposure similar to chest X-ray examination.

Authors:  Tobias A Fuchs; Julia Stehli; Sacha Bull; Svetlana Dougoud; Olivier F Clerc; Bernhard A Herzog; Ronny R Buechel; Oliver Gaemperli; Philipp A Kaufmann
Journal:  Eur Heart J       Date:  2014-02-19       Impact factor: 29.983

View more
  2 in total

1.  Predictors of abnormality in thallium myocardial perfusion scans for type 2 diabetes.

Authors:  Chieh-Hua Lu; Dee Pei; Chung-Ze Wu; Hui-Chun Kua; Yao-Jen Liang; Yen-Lin Chen; Jiunn-Diann Lin
Journal:  Heart Vessels       Date:  2020-08-20       Impact factor: 2.037

2.  APLP2 gene polymorphisms are associated with high TC and LDL-C levels in Chinese population in Xinjiang, China.

Authors:  Jialin Abuzhalihan; Dilare Adi; Yong-Tao Wang; Yang Li; Yi-Ning Yang; Xiang Ma; Xiao-Mei Li; Xiang Xie; Fen Liu; Bang-Dang Chen; Min-Tao Gai; Zhen-Yan Fu; Yi-Tong Ma
Journal:  Biosci Rep       Date:  2020-08-28       Impact factor: 3.840

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.